Avatcha, Production Firm, Limited Liability Company
Dr. A. Beck is Senior Director, Antibody Physico-Chemistry and member of the board of directors of the CIPF. He contributed to the R&D of anticancer mAbs (dalotuzumab/IGF-1R with Merck, h224G11/cMet with Abbott, h515H7/CXCR4, h6F4/JAM-A), vaccines and peptides. He is inventor on 16 patents, author of 80 publications, associate editor of mAbs (www.landesbioscience.com) and guest editor for special issues on mAbs (Nat Rev Immunol, Anal Chem, Curr Pharm Biotech, Medecine/ Sciences and Meth Mol Biol).
resented by the Society for Applied Spectroscopy; the Heinrich Award in 1995 presented by the Microbeam Analysis Society; the Washington Academy of Sciences Outstanding Contribution to the Physical Sciences